Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Specimen Handling 613pembrolizumab 568Magnetic Resonance Spectroscopy 538Carboplatin 429Cyclophosphamide 381Cisplatin 374Biopsy 355Paclitaxel 312Nivolumab 307Gemcitabine 302Radiotherapy 260Bevacizumab 237Dexamethasone 213fludarabine 207Docetaxel 189durvalumab 181atezolizumab 175Oxaliplatin 171Rituximab 167Fluorouracil 167venetoclax 166Pemetrexed 164Doxorubicin 161Capecitabine 158Radiation 157Radiosurgery 147Etoposide 138Leucovorin 134Ipilimumab 134Lenalidomide 132

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Laryngectomy × 90 days × Clear all
NCT07392580 2026-06-01

Intralesional Chemotherapy (IC): Cisplatin + Epinephrine

University of Miami

Phase 2 Recruiting
20 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡